Here are 10 highlights:
1. The company reported preliminary revenue of $3.6 million in the fourth quarter of 2016.
2. Preliminary GAAP net loss was $0.16 per share in the fourth quarter of 2016, compared to $0.57 per share in the fourth quarter of 2015.
3. In 2016, Amedica saw revenue of $15.2 million.
4. Preliminary GAAP net loss was $1.19 per share for the full year of 2016.
5. As of Dec. 31, 206, Amedica’s cash and cash equivalents were $6.9 million.
6. Amedica decreased its total debt to about $4 million, a reduction from the $24.3 million in July 2015.
7. Surgeons have completed more than 60 surgeries with Amedica’s Taurus Pedicle Screw System since its approval in November 2016. The company saw $450,000 in revenue from the system with an additional 10 surgeons trialing the system.
8. Since the end of 2016, Amedica has seen a 12 percent jump in surgeon users.
9. Amedica also reported a 10 percent increase in sales agents compared to the end of 2016.
10. Looking ahead, the company is focused on boosting revenue in Brazil, Europe and Australia.
More articles on devices:
48 orthopedic devices receive FDA 510(k) clearance in May 2017
New, noninvasive deep brain stimulation to treat Parkinson’s disease: 5 insights
Which product rakes in the best income for medical sales reps?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
